Contractile properties of EDL and soleus muscles of myostatin-deficient mice

Journal of Applied Physiology

Volumn 101, Issue 3, 2006, Pages 898-905

  Mendias, Christopher L ^a   Marcin, James E ^b   Calerdon, Daniel R ^b   Faulkner, John A ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

GDF 8; Muscle injury; Muscle morphology

Indexed keywords

ACTIVIN RECEPTOR 2; COLLAGEN; COLLAGEN TYPE 1; HYDROXYPROLINE; MYOSTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; EXTENSOR DIGITORUM LONGUS MUSCLE; IN VITRO STUDY; MALE; MOUSE; MUSCLE CONTRACTILITY; MUSCLE INJURY; MUSCLE TETANIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SOLEUS MUSCLE;

ANIMALS; EXTRACELLULAR MATRIX; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE, SKELETAL; STRESS, MECHANICAL; TRANSFORMING GROWTH FACTOR BETA;

EID: 33748476501     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00126.2006     Document Type: Article

References (71)

1. Allen RE, Temm-Grove CJ, Sheehan SM, and Rice G. Skeletal muscle satellite cell cultures. Methods Cell Biol 52: 155-176, 1997.
2. Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, and Patel K. Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis. Dev Biol 270: 19-30, 2004.
3. Bernasconi P, Torchiana E, Confalonieri P, Brugnoni R, Barresi R, Mora M, Cornelio F, Morandi L, and Mantegazza R. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J Clin Invest 96: 1137-1144, 1995.
4. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, and Khurana TS. Functional improvement of dystrophic muscle by myostatin blockade. Nature 420: 418-421, 2002.
5. Bogdanovich S, Perkins KJ, Krag TO, Whittemore LA, and Khurana TS. Myostatin propeptide-mediated amelioration of dystrophic pathophysiology. FASEB J 19: 543-549, 2005.
6. Brooks SV and Faulkner JA. Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol 404: 71-82, 1988.
7. Brooks SV and Faulkner JA. The magnitude of the initial injury induced by stretches of maximally activated muscle fibres of mice and rats increases in old age. J Physiol 497: 573-580, 1996.
8. Brooks SV, Zerba E, and Faulkner JA. Injury to muscle fibres after single stretches of passive and maximally stimulated muscles in mice. J Physiol 488: 459-469, 1995.
9. Byron CD, Hamrick MW, and Wingard CJ. Alterations of temporalis muscle contractile force and histological content from the myostatin and Mdx deficient mouse. Arch Oral Biol 51: 396-405, 2006.
10. Carlson CJ, Booth FW, and Gordon SE. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol Regul Integr Comp Physiol 277: R601-R606, 1999.
11. Consolino CM and Brooks SV. Susceptibility to sarcomere injury induced by single stretches of maximally activated muscles of mdx mice. J Appl Physiol 96: 633-638, 2004.
12. Contri MB, Guerra D, Vignali N, Taparelli F, Marcuzzi A, Caroli A, and Ronchetti IP. Ultrastructural and immunocytochemical study on normal human palmar aponeuroses. Anat Rec 240: 314-321, 1994.
13. Delforge G. Musculoskeletal Trauma: Implications for Sports Injury Management. Champaign, IL: Human Kinetics, 2002.
14. Dellorusso C, Crawford RW, Chamberlain JS, and Brooks SV. Tibialis anterior muscles in mdx mice are highly susceptible to contractioninduced injury. J Muscle Res Cell Motil 22: 467-475, 2001.
15. Donovan CM and Faulkner JA. Muscle grafts overloaded by ablation of synergistic muscles. J Appl Physiol 61: 288-292, 1986.
16. Ducomps C, Mauriege P, Darche B, Combes S, Lebas F, and Doutreloux JP. Effects of jump training on passive mechanical stress and stiffness in rabbit skeletal muscle: role of collagen. Acta Physiol Scand 178: 215-224, 2003.
17. Engvall E and Wewer UM. The new frontier in muscular dystrophy research: booster genes. FASEB J 17: 1579-1584, 2003.
18. Friden J and Lieber RL. Segmental muscle fiber lesions after repetitive eccentric contractions. Cell Tissue Res 293: 165-171, 1998.
19. Gosselin LE, Adams C, Cotter TA, McCormick RJ, and Thomas DP. Effect of exercise training on passive stiffness in locomotor skeletal muscle: role of extracellular matrix. J Appl Physiol 85: 1011-1016, 1998.
20. Grobet L, Martin LJ, Poncelet D, Pirottin D, Brouwers B, Riquet J, Schoeberlein A, Dunner S, Menissier F, Massabanda J, Fries R, Hanset R, and Georges M. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 17: 71-74, 1997.
21. Grobet L, Pirottin D, Farnir F, Poncelet D, Royo LJ, Brouwers B, Christians E, Desmecht D, Coignoul F, Kahn R, and Georges M. Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene. Genesis 35: 227-238, 2003.
22. Hanyu T, Tajima T, Takagi T, Sasaki S, Fujimoto D, Isemura M, and Yosizawa Z. Biochemical studies on the collagen of the palmar aponeurosis affected with Dupuytren's disease. Tohoku J Exp Med 142: 437-443, 1984.
23. Huijing P. Muscular force transmission: a unified, dual or multiple system? A review and some explorative experimental results. Arch Physiol Biochem 107: 292-311, 1999.
24. Kambadur R, Sharma M, Smith TP, and Bass JJ. Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res 7: 910-916, 1997.
25. Kandarian SC and White TP. Mechanical deficit persists during longterm muscle hypertrophy. J Appl Physiol 69: 861-867, 1990.
26. Khurana TS and Davies KE. Pharmacological strategies for muscular dystrophy. Nat Rev Drug Discov 2: 379-390, 2003.
27. Kjaer M. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 84: 649-698, 2004.
28. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, and Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 277: 49831-49840, 2002.
29. Lee SJ and McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98: 9306-9311, 2001.
30. Lesch M, Parmley WW, Hamosh M, Kaufman S, and Sonnenblick EH. Effects of acute hypertrophy on the contractile properties of skeletal muscle. Am J Physiol 214: 685-690, 1968.
31. Light N and Champion AE. Characterization of muscle epimysium, perimysium and endomysium collagens. Biochem J 219: 1017-1026, 1984.
32. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] method. Methods 25: 402-408, 2001.
33. Macpherson PC, Dennis RG, and Faulkner JA. Sarcomere dynamics and contraction-induced injury to maximally activated single muscle fibres from soleus muscles of rats. J Physiol 500: 523-533, 1997.
34. Macpherson PC, Schork MA, and Faulkner JA. Contraction-induced injury to single fiber segments from fast and slow muscles of rats by single stretches. Am J Physiol Cell Physiol 271: C1438-C1446, 1996.
35. Mahoney DJ, Carey K, Fu MH, Snow R, Cameron-Smith D, Parise G, and Tarnopolsky MA. Real-time RT-PCR analysis of housekeeping genes in human skeletal muscle following acute exercise. Physiol Genomics 18: 226-231, 2004.
36. Martyn JK, Bass JJ, and Oldham JM. Skeletal muscle development in normal and double-muscled cattle. Anat Rec A Discov Mol Cell Evol Biol 281: 1363-1371, 2004.
37. Matsakas A, Friedel A, Hertrampf T, and Diel P. Short-term endurance training results in a muscle-specific decrease of myostatin mRNA content in the rat. Acta Physiol Scand 183: 299-307, 2005.
38. Maxwell LC, Faulkner JA, and Hyatt GJ. Estimation of number of fibers in guinea pig skeletal muscles. J Appl Physiol 37: 259-264, 1974.
39. McCroskery S, Thomas M, Maxwell L, Sharma M, and Kambadur R. Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 162: 1135-1147, 2003.
40. McCroskery S, Thomas M, Platt L, Hennebry A, Nishimura T, McLeay L, Sharma M, and Kambadur R. Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice. J Cell Sci 118: 3531-3541, 2005.
41. McMahon CD, Popovic L, Oldham JM, Jeanplong F, Smith HK, Kambadur R, Sharma M, Maxwell L, and Bass JJ. Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension. Am J Physiol Endocrinol Metab 285: E82-E87, 2003.
42. McPherron AC, Lawler AM, and Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387: 83-90, 1997.
43. Mendler L, Zador E, Ver Heyen M, Dux L, and Wuytack F. Myostatin levels in regenerating rat muscles and in myogenic cell cultures. J Muscle Res Cell Motil 21: 551-563, 2000.
44. Neuman RE and Logan MA. The determination of hydroxyproline. J Biol Chem 184: 299-306, 1950.
45. Patel K and Amthor H. The function of myostatin and strategies of myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle. Neuromuscul Disord 15: 117-126, 2005.
46. Philip B, Lu Z, and Gao Y. Regulation of GDF-8 signaling by the p38 MAPK. Cell Signal 17: 365-375, 2005.
47. Pirottin D, Grobet L, Adamantidis A, Farnir F, Herens C, Daa Schroder H, and Georges M. Transgenic engineering of male-specific muscular hypertrophy. Proc Natl Acad Sci USA 102: 6413-6418, 2005.
48. Prado LG, Makarenko I, Andresen C, Kruger M, Opitz CA, and Linke WA. Isoform diversity of giant proteins in relation to passive and active contractile properties of rabbit skeletal muscles. J Gen Physiol 126: 461-480, 2005.
49. Prentice WE. Rehabilitation Techniques in Sports Medicine and Athletic Training. New York: McGraw-Hill, 2004.
50. Rebbapragada A, Benchabane H, Wrana JL, Celeste AJ, and Attisano L. Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol 23: 7230-7242, 2003.
51. Rehfeldt C, Ott G, Gerrard DE, Varga L, Schlote W, Williams JL, Renne U, and Bunger L. Effects of the compact mutant myostatin allele Mstn (Cmpt-dl1Abc) introgressed into a high growth mouse line on skeletal muscle cellularity. J Muscle Res Cell Motil 26: 103-112, 2005.
52. Reisz-Porszasz S, Bhasin S, Artaza JN, Shen R, Sinha-Hikim I, Hogue A, Fielder TJ, and Gonzalez-Cadavid NF. Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Endocrinol Metab 285: E876-E888, 2003.
53. Roth SM and Walsh S. Myostatin: a therapeutic target for skeletal muscle wasting. Curr Opin Clin Nutr Metab Care 7: 259-263, 2004.
54. Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, and Lee SJ. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350: 2682-2688, 2004.
55. Sharma M, Langley B, Bass J, and Kambadur R. Myostatin in muscle growth and repair. Exerc Sport Sci Rev 29: 155-158, 2001.
56. 12 muscle cells. Am J Physiol Endocrinol Metab 280: E221-E228, 2001.
57. Thies RS, Chen T, Davies MV, Tomkinson KN, Pearson AA, Shakey QA, and Wolfman NM. GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding. Growth Factors 18: 251-259, 2001.
58. Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, and Kambadur R. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275: 40235-40243, 2000.
59. Tobin JF and Celeste AJ. Myostatin, a negative regulator of muscle mass: implications for muscle degenerative diseases. Curr Opin Pharmacol 5: 328-332, 2005.
60. Verrecchia F and Mauviel A. TGF-beta and TNF-alpha: antagonistic cytokines controlling type I collagen gene expression. Cell Signal 16: 873-880, 2004.
61. Wagner KR. Muscle regeneration through myostatin inhibition. Curr Opin Rheumatol 17: 720-724, 2005.
62. Wagner KR, Liu X, Chang X, and Allen RE. Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci USA 102: 2519-2524, 2005.
63. Wagner KR, McPherron AC, Winik N, and Lee SJ. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 52: 832-836, 2002.
64. Wanke T, Toifl K, Merkle M, Formanek D, Lahrmann H, and Zwick H. Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest 105: 475-482, 1994.
65. Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, Hill JJ, Jalenak M, Kelley P, Knight A, Maylor R, O'Hara D, Pearson A, Quazi A, Ryerson S, Tan XY, Tomkinson KN, Veldman GM, Widom A, Wright JF, Wudyka S, Zhao L, and Wolfman NM. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 300: 965-971, 2003.
66. Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 93: 440-447, 1961.
67. Wolfman NM, McPherron AC, Pappano WN, Davies MV, Song K, Tomkinson KN, Wright JF, Zhao L, Sebald SM, Greenspan DS, and Lee SJ. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci USA 100: 15842-15846, 2003.
68. Yang J, Ratovitski T, Brady JP, Solomon MB, Wells KD, and Wall RJ. Expression of myostatin pro domain results in muscular transgenic mice. Mol Reprod Dev 60: 351-361, 2001.
69. Zhu X, Hadhazy M, Wehling M, Tidball JG, and McNally EM. Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett 474: 71-75, 2000.
70. Zhu X, Topouzis S, Liang LF, and Stotish RL. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine 26: 262-272, 2004.
71. Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM, and Lee SJ. Induction of cachexia in mice by systemically administered myostatin. Science 296: 1486-1488, 2002.